K Malarvizhi, B N Vedha Hari, P Rajalakshmi, S Devaraj, Durai Ramyadevi
Pharmaceutical Technology Laboratory, School of Chemical & Biotechnology, SASTRA Deemed University #214, ASK-II Thanjavur-613401 India
Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences Sienkiewicza 112 90-363 Lodz Poland.
RSC Med Chem. 2023 May 1;14(6):1143-1157. doi: 10.1039/d3md00123g. eCollection 2023 Jun 22.
Metallopharmaceuticals possess unique medicinal properties and have been used since ancient times. In spite of the inclusion of several metals and minerals, there is an increased interest in metallo-drugs for clinical and research purposes because of their immense therapeutic efficiency and non-toxic claim, as they are processed in addition to specific poly herbals. is one of the traditional metallopharmaceuticals used in Siddha medicine to treat various respiratory diseases and other ailments, including antidote therapy for poisonous bites. The present research work attempted to formulate the metallodrug preparation as per the standard protocols, including the detoxification process of the raw materials, followed by the analytical characterization studies to evaluate the physicochemical properties responsible for the stability, quality, and efficacy. The study included the comparative analysis of the raw materials, processed samples, intermediate samples, finished products, and commercial samples to understand the science involved in detoxification and formulation processing. The appropriate product profile was developed based on analysis of the particle size and surface charge by Zeta sizer, morphology and distribution by SEM-EDAX, functional groups and chemical interactions by FTIR, thermal behavior and stability by TG-DSC, crystallinity by XRD, and elemental composition by XPS. The findings of the research could provide scientific proof of evidence to overcome the limitations of the product owing to the standard quality and safety concern of the metal-mineral constituents, such as mercury, sulphur, and arsenic in the polyherbomineral formulation.
金属药物具有独特的药用特性,自古以来就被使用。尽管包含多种金属和矿物质,但由于金属药物具有巨大的治疗效果且声称无毒,同时它们还与特定的复方草药一起加工,因此出于临床和研究目的,人们对金属药物的兴趣日益增加。[某种物质]是悉达医学中用于治疗各种呼吸系统疾病和其他疾病(包括毒蛇咬伤的解毒疗法)的传统金属药物之一。本研究工作试图按照标准方案制备金属药物制剂,包括原材料的解毒过程,随后进行分析表征研究,以评估负责稳定性、质量和功效的物理化学性质。该研究包括对原材料、加工样品、中间样品、成品和商业样品的比较分析,以了解解毒和制剂加工过程中涉及的科学原理。通过Zeta粒度分析仪分析粒径和表面电荷、通过扫描电子显微镜-能谱仪(SEM-EDAX)分析形态和分布、通过傅里叶变换红外光谱仪(FTIR)分析官能团和化学相互作用、通过热重-差示扫描量热仪(TG-DSC)分析热行为和稳定性、通过X射线衍射仪(XRD)分析结晶度以及通过X射线光电子能谱仪(XPS)分析元素组成,从而制定了合适的产品概况。该研究结果可以提供科学证据,以克服由于多草药矿物配方中金属矿物成分(如汞、硫和砷)的标准质量和安全问题而导致的产品局限性。